Class 2 medicine recallHigh riskMedicine · 8 Oct 2019
GlaxoSmithKline, trading as Glaxo Welcome Ltd, is recalling all unexpired stock of Zantac (ranitidine hydrochloride) prescription only medicines (POM) from pharmacies.
Class 4 medicine recallMedicine · 3 Oct 2019
The MHRA has notified Bausch and Lomb UK Limited of reports that Emerade pens have failed to activate. The MHRA is advising that Emerade devices should not be recalled.
Class 2 medicine recallHigh riskMedicine · 23 Sep 2019
Martindale Pharmaceuticals Limited is recalling the above batch due to an issue with homogeneity.
Class 2 medicine recallHigh riskMedicine · 12 Sep 2019
Dr. Reddy's Laboratories (UK) Ltd is recalling the above batch due to the potential for small particles of Aripiprazole active material to be present which may affect the efficacy of the product.
Class 2 medicine recallHigh riskMedicine · 30 Jul 2019
Accord-UK Ltd is recalling the above batches due to the potential for small particles of Aripiprazole active material to be present which may affect the efficacy of the product. No relevant product complaints or…
Class 2 medicine recallHigh riskMedicine · 25 Jul 2019
Medicines have been taken out of the regulated medicines’ supply chain during distribution. The products have been parallel imported into the UK by Kosei Pharma, CST Pharma and Ordinant Medical Solutions from Italy and…
Class 2 medicine recallHigh riskMedicine · 24 Jul 2019
Chanelle Medical is recalling the above batch because a small number of packs have been found to contain tablets which are stuck together, with mould observed on some tablets. The mould has been identified…
Class 4 medicine recallMedicine · 11 Jul 2019
Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) has informed us of a risk of Emerade product failing to deliver a dose of adrenaline from the syringe due to blockage…
Class 4 medicine recallMedicine · 8 Jul 2019
Martindale Pharma has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that the EAN bar code for the following batches is incorrect.
Class 2 medicine recallHigh riskMedicine · 27 Jun 2019
Medicines have been taken out of the regulated medicines’ supply chain during distribution. The products have been parallel imported into the UK by B & S Healthcare from Italy and have been re-labelled in…
Medicine recallMedicine · 24 Jun 2019
Pfizer UK Limited is recalling batches as routine stability testing has identified that levels of a known impurity, 10-oxo-docetaxel, may exceed the acceptable level at end of shelf-life.
Class 2 medicine recallHigh riskMedicine · 13 Jun 2019
M & A Pharmachem is recalling the above batches because a small number of pots from each batch have been found to contain discoloured tablets due to fungal contamination.
Class 4 medicine recallMedicine · 3 Jun 2019
Baxter Healthcare Limited has informed us that a quality defect has been identified with the above product where the front panel of a small number of infusion bags was found to be missing the…
Class 2 medicine recallHigh riskMedicine · 13 May 2019
Sandoz Ltd. have been notified of a potential packaging problem relating to poor seal adherence which could cause clumping of the powder within the bottle.
Medicine recallMedicine · 7 May 2019
Macopharma is recalling certain batches of intravenous infusion bags as a precaution. This is due to the detection of metal particles in two infusion bags.
Class 4 medicine recallMedicine · 26 Apr 2019
Genesis Pharmaceuticals Ltd has informed us that there is an error on the Braille for the above batches which means that the strength reads as 1mg instead of 5mg. The printed text is correct…
Class 4 medicine recallMedicine · 24 Apr 2019
Pfizer Limited has informed us that the text on the carton label for the above product has recently been updated and at this time, the product description on the carton was changed from 10…
Class 4 medicine recallMedicine · 9 Apr 2019
Martindale Pharmaceuticals has informed us of two issues with all unexpired batches of the above product, PL 00156/0109, legal status ‘P’. The Braille is missing from the carton and the packs contain the Patient…
Medicine recallMedicine · 8 Apr 2019
B. Braun Medical Ltd is Recalling batches as ongoing stability studies have identified that they may have an out of specification result in the glucose chamber at the end of shelf-life.
Class 4 medicine recallMedicine · 4 Apr 2019
Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed us that some packs from a batch of Zoledronic acid 5mg solution for infusion contain a Patient Information Leaflet for Temozolomide 180mg Capsules.
Class 2 medicine recallHigh riskMedicine · 20 Mar 2019
Further to previous recalls of Valsartan and Irbesartan containing products, which were potentially contaminated with N-nitrosodimethylamine (NDMA) or N-nitrosodiethylamine (NDEA), we have become aware of products containing Losartan Potassium that are contaminated with a…
Medicine recallMedicine · 18 Mar 2019
Allergan Pharmaceuticals Ireland is further recalling batches due to the possibility that a single loose silicone particle of approximately 300 microns in diameter may become detached.
Class 4 medicine recallMedicine · 28 Feb 2019
Accord Healthcare Limited has informed us that there is an error on the portion of the Patient Information Leaflet (PIL) for the Paracetamol Infusion which is intended for Healthcare Professionals.
Medical device alertMedicine · 19 Feb 2019
Manufactured by Roche Diabetes Care – Important instructions on how to fit 2 separate key frames to prevent accidentally activating the pump (MDA/2019/009).